[AF] Australian Prescriber Volume 27 Number 6. ADRAC Bulletin, Vol.23, no.6

[Martín Cañás]

Estimadas y estimados colisteros,
con dos idas y vueltas interesantes sobre nuevos medicamentos y sobre las ventajas de los antipsicóticos atípicos está disponible en la red el 
 
Australian Precriber Volume 27 Number 6 December 2004      
 
cuyo índice es:
 
Expensive new drugs – do we really need them? (Editorial) R.F.W. Moulds    
The need for new drugs: a response (Editorial) J.A. Whitworth   
Letters  
Medicines Australia Code of Conduct: breaches
The vascular effects of COX-2 selective inhibitors R.O. Day   G.G. Graham   
Are atypical antipsychotics advantageous? – the case for   N.A. Keks   
Are atypical antipsychotics advantageous? – the case against  V. Carr    
Perioperative analgesia   S.A. Schug   P. Dodd
   
What does TGA approval of medicines mean? J. McEwen   
Book review  Drugs and breastfeeding Your questions to the PBAC  
Book review  Pocket guide to chest X-rays   
Book review   Health care and notions of risk   
New drugs   adefovir, anakinra, atazanavir, cholera vaccine, enfuvirtide, gadobenate, treprostinil 
 
Está disponible en:
http://www.australianprescriber.com/index.php?content=/magazines/vol27no6/index.htm
 
 
 
También con datos sobre las vedettes del año (COX-2 y ISRS en niños) 
está disponible el 
Australian Adverse Drug Reactions Bulletin, Vol.23, no.6 (December 2004)
 

Use of SSRI antidepressants in children and adolescents
Cardiovascular risk with the selective COX-2 inhibitors
Propofol: danger of prolonged and high infusion rates in ICU 
 
La dirección es:
http://www.tga.gov.au/adr/aadrb/aadr0412.htm

 

Saludos
Martín
La Plata, Argentina
macanas en netverk.com.ar
_______________________________________________